Empowerment program to reduce HIV risk for transmasculine people
Part of Immune system & allergy, Infections clinical trials.
This study tests a program designed for transmasculine individuals (people assigned female at birth who identify as men or another transmasculine identity) to help reduce HIV risk. The program includes one-on-one and group support to encourage the use of PrEP (a daily pill that prevents HIV). You may be eligible if you are HIV-negative, live in certain high-priority U.S. areas, and have recent HIV risk factors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You were assigned female at birth and identify as a man, trans man, or other transmasculine identity.
- You are HIV-negative (not living with HIV).
- You have access to a smartphone or computer with internet.
- You live in one of the Ending the Epidemic geographic hotspots in the United States.
- In the last 3 months, you have had sex without a condom with a partner who has a penis, shared needles for drugs or hormones, or been diagnosed with an STI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new approach to help men at risk for HIV stay healthy by providing access to PrEP through a mobile app. The goal is to see if the program helps men start and stay on PrEP compared to standard care.
This study helps transgender women who are not regularly using PrEP (a daily pill to prevent HIV) get access to HIV prevention services. It uses a smartphone to take pictures and connect with support.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
This study tests a '2-1-1' on-demand PrEP strategy for cisgender men who have sex with men. It aims to see if taking PrEP only around the time of sex is safe and effective. If you are interested in starting or currently taking PrEP this way, you may be eligible.
This trial tests ways to improve how well people take PrEP (a medicine that helps prevent HIV) consistently. It may help you if you’re at higher risk and are not currently on PrEP, especially around starting and staying on it.
This study tests a behavioral program to help men who have sex with men start using PrEP, a daily pill that prevents HIV. It is designed for those at high risk for HIV who have not used PrEP before.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.